Dr. Catherine Rees Lintzenich, MD

Dr. Lintzenich practices at Doctors Surgery Center - HOPD in Williamsburg, Virginia.

Dr. Lintzenich's NPI, 1427019793, was assigned on March 28, 2006. Dr. Lintzenich holds Virginia license 0101255627.

Dr. Lintzenich's primary practice is Doctors Surgery Center - HOPD, at 120 Kings Way, Williamsburg, VA 23185.

Dr. Lintzenich's primary practice is Doctors Surgery Center - HOPD in Williamsburg, Virginia. Dr. Lintzenich is also affiliated with Riverside Doctors' Hospital Williamsburg. The medical group on file is Riverside Gastroenterology Specialists. Dmand AI also links Dr. Lintzenich to 2 more hospitals, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lintzenich practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Lintzenich's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Lintzenich's licenses on file in 2 states: Virginia and North Carolina.

CMS data shows 1,362 Medicare services from Dr. Lintzenich across 10 procedure codes in 2024, for 788 Medicare patients. Medicare paid $62,109 for them.

CMS counts 788 Medicare patients who saw Dr. Lintzenich in 2024. The largest group is 75 to 84, with 321 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lintzenich's median patient age at 69, with 62% women.

In 2024, Dr. Lintzenich wrote 774 Medicare Part D claims for 286 patients. 95% of them were for generic drugs. CMS names the drug for 652 of them, across 20 drugs with 11 or more claims each, at $13,344 in total drug cost. In 2023, CMS named 667 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Lintzenich for performance year 2024, reported through an alternative payment model (APM). Dr. Lintzenich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Lintzenich, published from 2011 to 2014. 2013 was the busiest year, with 4. The most frequent topics are Deglutition, Deglutition Disorders and Administration, Intranasal. Dr. Lintzenich has published most often in Laryngoscope. Dr. Lintzenich's most frequent co-authors are Stephen C. Wright, MD, James Dale Browne, MD and Tim A. Fife, MD.

CMS Open Payments shows 123 general payments to Dr. Lintzenich from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Intersect ENT, Inc. paid the most, $1,038.